If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,842.00
Bid: 2,839.00
Ask: 2,842.00
Change: -132.00 (-4.44%)
Spread: 3.00 (0.106%)
Open: 2,883.00
High: 2,898.00
Low: 2,811.00
Prev. Close: 2,974.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual General Meeting

18 Jul 2013 07:01

RNS Number : 5770J
3i Group PLC
18 July 2013
 



3i Group plc

18 July 2013

 

 

 

Annual General Meeting

 

At the Annual General Meeting of 3i Group plc at 11.00am this morning, Sir Adrian Montague, Chairman, will comment:

 

"Our results for the financial year to 31 March 2013 show significant improvement compared to the prior year, particularly in our Private Equity business.

 

As outlined in this morning's Interim Management Statement, we've had a strong start to the current financial year, with the NAV per share growing by 5% from 31 March 2013 to 326p per share at 30 June 2013, which reflects the continued underlying growth in earnings in the Private Equity portfolio and also a number of good realisations."

 

In the Company's Interim Management Statement relating to the three-month period from 1 April 2013 to 30 June 2013, which was released earlier this morning, Chief Executive, Simon Borrows, said that:

 

"We are making good progress in the next phase of 3i's strategic plan, transition and delivery.

 

We have enjoyed a busy run of divestment activity. The £443 million of realisations we have completed or announced in the first quarter of FY 2014 are encouraging and will support our policy to distribute 15%-20% of gross realisation proceeds. The total amount in our distribution calculation for FY 2014 so far is £665 million, including the £222 million for Mold-Masters received last year."

 

For more information, please refer to the Interim Management Statement published this morning.

 

Ends

 

 

For information, please contact:

 

 

Kathryn van der KroftCommunications Director, 3i Group plc

020 7975 3021

 

Silvia Santoro

Investor Relations Director, 3i Group plc

 

020 7975 3258

 

 

 

Notes to editors

3i is a leading international investor focused on mid-market private equity, infrastructure and debt management across Europe, Asia and the Americas.

 

For further information, please visit: www.3i.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFIADRIDLIV
Date   Source Headline
9th May 20247:00 amRNSResults for the year to 31 March 2024
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.